GlassScriptPhysician profile
Paul Magda
NPI 1750353561
$389.02
in general payments reported to CMS, 2019-2025
12 companies · $32.71 in 2025
The $32.71 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $99.96 · 2021: $89.68 · 2022: $33.01 · 2025: $32.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $130.44 | 2019-2020 | |
| Life Molecular Imaging LTD | $33.01 | 2022 | |
| Tg Therapeutics, INC. | $32.71 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $25.00 | 2021 | |
| Neurelis, INC. | $23.74 | 2020 | |
| Avanir Pharmaceuticals, INC. | $23.73 | 2019 | |
| Sk Life Science, INC. | $23.37 | 2021 | |
| Biogen, INC. | $22.26 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $19.88 | 2020 | |
| Ucb, INC. | $19.05 | 2021 | |
| Sunovion Pharmaceuticals INC. | $18.58 | 2020 | |
| Genentech USA, INC. | $17.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Magda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.